Core Insights - The article discusses the top ASX companies that have gained attention in Week 8, highlighting market trends and potential investment opportunities. Group 1: Forte Energy - Forte Energy (ASX:FEL) attracted significant interest with a new acquisition of 143,368 acres of "highly prospective" leases in Alaska for oil exploration [3][4] - The acquired land consists of 11 exploration leases located on proven petroleum systems, previously explored by XCD Energy and 88 Energy [4] - The company's current share price is at 0.6 cents per share, indicating it remains a micro-cap stock [4] Group 2: LDR Capital Property - LDR Capital Property (ASX:LED) has rebranded from "ECF I" and "ECF II" following the completion of LDR Asset's takeover of the Elanor Commercial Property Fund [5][6] - The takeover was finalized at 70 cents per share, merging Elanor and LDR into a larger asset management entity [6] - The current share price for LDR is 5.8 cents per share [6] Group 3: Pro Medicus - Pro Medicus (ASX:PME), a $13 billion healthcare imaging company, is experiencing increased interest as it may be entering a 'value' range after a -43.2% year-to-date decline [7][8] - The company reported first-half FY26 revenue of A$128.94 million and net income of A$171.22 million, alongside a dividend announcement of 32 cents per share [8] - The current share price for Pro Medicus is $125.53 per share, significantly lower than its previous peak of $327 [8] Group 4: Other Companies - Other companies mentioned in the HotList include Zip Co, WiseTech, CSL Ltd, LinQ Minerals, Botanix Pharmaceuticals, Xero Limited, and Telix Pharma [8][9]

Core Viewpoint - Nokia and Celesta Capital have launched Astranu, a company focused on advancing healthcare imaging technology, specifically in hearing care through next-generation imaging technology [1][9]. Group 1: Company Overview - Astranu has spun out from Nokia as part of a collaboration aimed at accelerating the commercialization of innovative technologies [1]. - The company leverages proprietary integrated Optical Coherence Tomography (iOCT) technology developed by Nokia Bell Labs, which aims to transform ear diagnostic care through advanced, non-invasive, high-resolution 3D imaging [2][9]. - Trevor Hawkins, PhD, an experienced healthcare technology executive, has been appointed as CEO of Astranu, bringing decades of leadership in scaling healthcare and diagnostic startups [3]. Group 2: Technology and Impact - The iOCT technology provides instant, high-accuracy imaging of middle-ear conditions and hearing response, potentially reducing misdiagnosis and unnecessary referrals while decreasing reliance on costly and invasive procedures like CT and MRI scans [2]. - Astranu's imaging technology is positioned to deliver high-resolution insights at the point of care, which could significantly enhance patient outcomes [7]. Group 3: Support and Collaboration - Nokia Bell Labs will continue to support Astranu with essential laboratory resources and R&D expertise, reinforcing their commitment to fostering impactful innovations [4]. - Celesta Capital's involvement provides strategic direction, commercialization support, and access to substantial industry networks, which are crucial for the rapid market adoption of Astranu's technology [5][6].